# Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters

> **NCT02708901** · NA · COMPLETED · sponsor: **IRCCS Fondazione Stella Maris** · enrollment: 85 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Vivomixx®
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02708901
- **Lead sponsor:** IRCCS Fondazione Stella Maris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-08
- **Final completion:** 2018-09
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2019-02-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02708901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02708901, "Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02708901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*